Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size, Status and Forecast 2024-2031

Report ID: 953220 | Published Date: Jan 2025 | No. of Page: 100 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Buspirone
        1.2.3 Bupropion
        1.2.4 Testosterone
        1.2.5 Flibanserin
        1.2.6 Bremelanotide
        1.2.7 Cognitive Behavior Therapy
    1.3 Market by Application
        1.3.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinic
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Perspective (2016-2027)
    2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Growth Trends by Regions
        2.2.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Industry Dynamic
        2.3.1 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
        2.3.2 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
        2.3.3 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
        2.3.4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue
        3.1.1 Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue
    3.4 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio
        3.4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2020
    3.5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Key Players Head office and Area Served
    3.6 Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
    3.7 Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Type
    4.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2022-2027)

5 Hypoactive Sexual Desire Disorder (HSDD) Treatment Breakdown Data by Application
    5.1 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
    6.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        6.2.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
    6.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        6.3.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
    6.4 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        6.4.1 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
    7.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        7.2.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
    7.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        7.3.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
    7.4 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        7.4.1 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        8.2.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        8.3.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region
        8.4.1 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
    9.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        9.2.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        9.3.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        9.4.1 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type
        10.2.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application
        10.3.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country
        10.4.1 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AMAG Pharmaceuticals
        11.1.1 AMAG Pharmaceuticals Company Details
        11.1.2 AMAG Pharmaceuticals Business Overview
        11.1.3 AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.1.4 AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.1.5 AMAG Pharmaceuticals Recent Development
    11.2 Allergan, Plc.
        11.2.1 Allergan, Plc. Company Details
        11.2.2 Allergan, Plc. Business Overview
        11.2.3 Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.2.4 Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.2.5 Allergan, Plc. Recent Development
    11.3 Ivix LLX
        11.3.1 Ivix LLX Company Details
        11.3.2 Ivix LLX Business Overview
        11.3.3 Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.3.4 Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.3.5 Ivix LLX Recent Development
    11.4 EndoCeutics, Inc.
        11.4.1 EndoCeutics, Inc. Company Details
        11.4.2 EndoCeutics, Inc. Business Overview
        11.4.3 EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.4.4 EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.4.5 EndoCeutics, Inc. Recent Development
    11.5 Emotional Brain BV
        11.5.1 Emotional Brain BV Company Details
        11.5.2 Emotional Brain BV Business Overview
        11.5.3 Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.5.4 Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.5.5 Emotional Brain BV Recent Development
    11.6 S1 Biopharma, Inc.
        11.6.1 S1 Biopharma, Inc. Company Details
        11.6.2 S1 Biopharma, Inc. Business Overview
        11.6.3 S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.6.4 S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.6.5 S1 Biopharma, Inc. Recent Development
    11.7 Sprout Pharmaceuticals, Inc.
        11.7.1 Sprout Pharmaceuticals, Inc. Company Details
        11.7.2 Sprout Pharmaceuticals, Inc. Business Overview
        11.7.3 Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Introduction
        11.7.4 Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
        11.7.5 Sprout Pharmaceuticals, Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Buspirone
    Table 3. Key Players of Bupropion
    Table 4. Key Players of Testosterone
    Table 5. Key Players of Flibanserin
    Table 6. Key Players of Bremelanotide
    Table 7. Key Players of Cognitive Behavior Therapy
    Table 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 11. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2016-2021)
    Table 12. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2022-2027)
    Table 14. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Trends
    Table 15. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Drivers
    Table 16. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Challenges
    Table 17. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Restraints
    Table 18. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 19. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players (2016-2021)
    Table 20. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2020)
    Table 21. Ranking of Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Companies by Revenue (US$ Million) in 2020
    Table 22. Global 5 Largest Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Hypoactive Sexual Desire Disorder (HSDD) Treatment Product Solution and Service
    Table 25. Date of Enter into Hypoactive Sexual Desire Disorder (HSDD) Treatment Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 28. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2016-2021)
    Table 29. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 30. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 31. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 32. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2016-2021)
    Table 33. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 34. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 35. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 36. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 37. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 38. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 39. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 40. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 41. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 42. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 43. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 44. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 45. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 46. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 47. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 50. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 52. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 53. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 54. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 55. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 56. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 57. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 58. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 59. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 62. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 64. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 65. AMAG Pharmaceuticals Company Details
    Table 66. AMAG Pharmaceuticals Business Overview
    Table 67. AMAG Pharmaceuticals Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 68. AMAG Pharmaceuticals Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 69. AMAG Pharmaceuticals Recent Development
    Table 70. Allergan, Plc. Company Details
    Table 71. Allergan, Plc. Business Overview
    Table 72. Allergan, Plc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 73. Allergan, Plc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 74. Allergan, Plc. Recent Development
    Table 75. Ivix LLX Company Details
    Table 76. Ivix LLX Business Overview
    Table 77. Ivix LLX Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 78. Ivix LLX Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 79. Ivix LLX Recent Development
    Table 80. EndoCeutics, Inc. Company Details
    Table 81. EndoCeutics, Inc. Business Overview
    Table 82. EndoCeutics, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 83. EndoCeutics, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 84. EndoCeutics, Inc. Recent Development
    Table 85. Emotional Brain BV Company Details
    Table 86. Emotional Brain BV Business Overview
    Table 87. Emotional Brain BV Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 88. Emotional Brain BV Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 89. Emotional Brain BV Recent Development
    Table 90. S1 Biopharma, Inc. Company Details
    Table 91. S1 Biopharma, Inc. Business Overview
    Table 92. S1 Biopharma, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 93. S1 Biopharma, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 94. S1 Biopharma, Inc. Recent Development
    Table 95. Sprout Pharmaceuticals, Inc. Company Details
    Table 96. Sprout Pharmaceuticals, Inc. Business Overview
    Table 97. Sprout Pharmaceuticals, Inc. Hypoactive Sexual Desire Disorder (HSDD) Treatment Product
    Table 98. Sprout Pharmaceuticals, Inc. Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021) & (US$ Million)
    Table 99. Sprout Pharmaceuticals, Inc. Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Buspirone Features
    Figure 3. Bupropion Features
    Figure 4. Testosterone Features
    Figure 5. Flibanserin Features
    Figure 6. Bremelanotide Features
    Figure 7. Cognitive Behavior Therapy Features
    Figure 8. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application: 2020 VS 2027
    Figure 9. Hospitals Case Studies
    Figure 10. Clinic Case Studies
    Figure 11. Others Case Studies
    Figure 12. Hypoactive Sexual Desire Disorder (HSDD) Treatment Report Years Considered
    Figure 13. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 14. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 15. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions: 2020 VS 2027
    Figure 16. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Regions (2022-2027)
    Figure 17. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Players in 2020
    Figure 18. Global Top Hypoactive Sexual Desire Disorder (HSDD) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hypoactive Sexual Desire Disorder (HSDD) Treatment as of 2020
    Figure 19. The Top 10 and 5 Players Market Share by Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue in 2020
    Figure 20. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2016-2021)
    Figure 21. Global Hypoactive Sexual Desire Disorder (HSDD) Treatment Revenue Market Share by Type (2022-2027)
    Figure 22. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 24. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 25. North America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 26. United States Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Canada Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 30. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 31. Europe Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 32. Germany Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. France Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. U.K. Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Italy Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Russia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Nordic Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 40. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 41. Asia-Pacific Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Region (2016-2027)
    Figure 42. China Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Japan Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. South Korea Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Southeast Asia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. India Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Australia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 50. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 51. Latin America Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 52. Mexico Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Brazil Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Type (2016-2027)
    Figure 56. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Application (2016-2027)
    Figure 57. Middle East & Africa Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Share by Country (2016-2027)
    Figure 58. Turkey Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Saudi Arabia Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. UAE Hypoactive Sexual Desire Disorder (HSDD) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. AMAG Pharmaceuticals Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 62. Allergan, Plc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 63. Ivix LLX Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 64. EndoCeutics, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 65. Emotional Brain BV Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 66. S1 Biopharma, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 67. Sprout Pharmaceuticals, Inc. Revenue Growth Rate in Hypoactive Sexual Desire Disorder (HSDD) Treatment Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AMAG Pharmaceuticals
Allergan, Plc.
Ivix LLX
EndoCeutics, Inc.
Emotional Brain BV
S1 Biopharma, Inc.
Sprout Pharmaceuticals, Inc.
Frequently Asked Questions
Hypoactive Sexual Desire Disorder (HSDD) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hypoactive Sexual Desire Disorder (HSDD) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hypoactive Sexual Desire Disorder (HSDD) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports